Laboratory Corporation of America Holdings Total Assets
Laboratory Corporation of America Holdings total assets. Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) holds total assets worth $19.09 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Laboratory Corporation of America Holdin operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Total Assets of Laboratory Corporation of America Holdings (1989–2025)
Total assets of Laboratory Corporation of America Holdings from 1989 to 2025. This chart illustrates how Laboratory Corporation of America Holdings's total assets have evolved over time, based on quarterly financial data. See Laboratory Corporation of America Holdin (LH) stock price for real-time trading data and today's change.
Laboratory Corporation of America Holdings - Asset Composition Analysis
Laboratory Corporation of America Holdings Total Assets Breakdown (December 2025)
Laboratory Corporation of America Holdings total assets breakdown as of December 2025. Laboratory Corporation of America Holdings's total assets of $19.09 Billion consist of 21.9% current assets and 78.1% non-current assets. Explore Laboratory Corporation of America Holdin (LH) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $532.30 Million | 2.9% |
| Accounts Receivable | $2.26 Billion | 12.3% |
| Inventory | $534.70 Million | 2.9% |
| Property, Plant & Equipment | $3.08 Billion | 16.8% |
| Intangible Assets | $3.60 Billion | 19.6% |
| Goodwill | $6.79 Billion | 36.9% |
Asset Composition Trend (1989–2025)
This chart illustrates how Laboratory Corporation of America Holdings's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laboratory Corporation of America Holdings's current assets represent 21.9% of total assets in 2025, a decrease from 30.8% in 1989.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2025, down from 8.7% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 55.0% of total assets, an increase from 0.0% in 1989.
- Asset Diversification: The largest asset category is goodwill at 36.9% of total assets.
Laboratory Corporation of America Holdings Competitors by Total Assets
Key competitors of Laboratory Corporation of America Holdings based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.00 Billion |
|
Chemclin Diagnostics Co. Ltd. A
SHG:688468
|
China | CN¥1.76 Billion |
|
Integrated Diagnostics Holdings PLC
LSE:IDHC
|
UK | $7.50 Billion |
|
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193
|
China | CN¥984.02 Million |
|
INIFY LABORATORIES AB
F:WY60
|
Germany | €204.64 Million |
|
INOVIQ LTD.
F:EGQ0
|
Germany | €21.71 Million |
|
Predilife
PA:ALPRE
|
France | €1.31 Million |
|
Wellfully Ltd
AU:WFL
|
Australia | AU$3.51 Million |
Laboratory Corporation of America Holdings - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 1.84 | 2.13 |
| Quick Ratio | 1.54 | 1.60 | 1.98 |
| Cash Ratio | 0.00 | 0.18 | 0.74 |
| Working Capital | $1.92 Billion | $1.73 Billion | $3.03 Billion |
Laboratory Corporation of America Holdings - Advanced Valuation Insights
This section examines the relationship between Laboratory Corporation of America Holdings's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.49 |
| Latest Market Cap to Assets Ratio | 1.18 |
| Asset Growth Rate (YoY) | 0.1% |
| Total Assets | $18.39 Billion |
| Market Capitalization | $21.71 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Laboratory Corporation of America Holdings's assets above their book value (1.18x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Laboratory Corporation of America Holdings's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Laboratory Corporation of America Holdings (1989–2025)
The table below shows the annual total assets of Laboratory Corporation of America Holdings from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $18.39 Billion | +0.07% |
| 2024-12-31 | $18.38 Billion | +9.89% |
| 2023-12-31 | $16.73 Billion | -17.02% |
| 2022-12-31 | $20.16 Billion | -1.13% |
| 2021-12-31 | $20.39 Billion | +1.56% |
| 2020-12-31 | $20.07 Billion | +11.38% |
| 2019-12-31 | $18.02 Billion | +11.34% |
| 2018-12-31 | $16.19 Billion | -2.31% |
| 2017-12-31 | $16.57 Billion | +16.29% |
| 2016-12-31 | $14.25 Billion | -0.27% |
| 2015-12-31 | $14.29 Billion | +95.65% |
| 2014-12-31 | $7.30 Billion | +5.07% |
| 2013-12-31 | $6.95 Billion | +2.05% |
| 2012-12-31 | $6.81 Billion | +10.35% |
| 2011-12-31 | $6.17 Billion | -0.27% |
| 2010-12-31 | $6.19 Billion | +27.33% |
| 2009-12-31 | $4.86 Billion | +4.07% |
| 2008-12-31 | $4.67 Billion | +6.90% |
| 2007-12-31 | $4.37 Billion | +9.18% |
| 2006-12-31 | $4.00 Billion | +3.23% |
| 2005-12-31 | $3.88 Billion | +7.63% |
| 2004-12-31 | $3.60 Billion | +5.45% |
| 2003-12-31 | $3.41 Billion | +30.75% |
| 2002-12-31 | $2.61 Billion | +35.35% |
| 2001-12-31 | $1.93 Billion | +15.76% |
| 2000-12-31 | $1.67 Billion | +4.82% |
| 1999-12-31 | $1.59 Billion | -3.09% |
| 1998-12-31 | $1.64 Billion | -1.06% |
| 1997-12-31 | $1.66 Billion | -13.48% |
| 1996-12-31 | $1.92 Billion | +4.34% |
| 1995-12-31 | $1.84 Billion | +81.42% |
| 1994-12-31 | $1.01 Billion | +72.96% |
| 1993-12-31 | $585.50 Million | +22.64% |
| 1992-12-31 | $477.40 Million | +16.07% |
| 1991-12-31 | $411.30 Million | +9.91% |
| 1990-12-31 | $374.20 Million | +1.63% |
| 1989-12-31 | $368.20 Million | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more